Medizinische Universität Graz - Research portal
Department of Obstetrics and Gynaecology
Division of General Gynaecology
SCI/PUBMED listed | all typs of publications | all by year and first author | MUG authors |
** = Publications listed in SCI/SSCI/Pubmed
Full paper/article (Journal)
** Banys-Paluchowski, M; Hartmann, S; Basali, T; Gasparri, ML; de, Boniface, J; Gentilini, OD; Cakmak, GK; Ditsch, N; Stickeler, E; Schlichting, E; Rubio, I; Peintinger, F; Untch, M; Mau, C; Federspiel, FK; Bucher, S; Ramaker, K; Paluchowski, P; Bauer, L; Riemer, S; Langanke, D; Leuf, TD; Schnabel, J; von, Abel, E; Solbach, C; Ovalle, SC; Hilmer, K; Bjelic-Radisic, V; Stahl, N; Sanchez-Mendez, JI; Hagen, V; Hansen, MH; Krawczyk, N; Sezen, BA; Jursik, K; Thill, M; Kolberg, HC; Reimer, T; Ruf, F; Wihlfahrt, K; Rief, A; Berger, T; Schmidt, E; Tauber, N; Fröhlich, S; Kühn, T
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.
Breast Cancer Res Treat. 2025;
Doi: 10.1007/s10549-025-07635-4
Web of Science
PubMed
FullText
FullText_MUG
** Cucinella, G; Schivardi, G; Zhou, XC; AlHilli, MM; Wallace, S; Covens, A; Wohlmuth, C; Baiocchi, G; Tokgozoglu, N; Raspagliesi, F; Buda, A; Zanagnolo, V; Zapardiel, I; Jagasia, N; Giuntoli, R; Glickman, A; Peiretti, M; Lanner, M; Chacon, E; Di, Guilmi, J; Pereira, A; Laas, E; Fishman, A; Nitschmann, CC; Kurnit, K; Moriarty, K; Joehlin-Price, A; Lees, B; De, Brot, L; Taskiran, C; Bogani, G; Landoni, F; Chiva, L; Grassi, T; Bianchi, T; Multinu, F; De, Vitis, LA; Hernandez-Gutierrez, A; Mastroyannis, S; Ghoniem, K; Palmieri, E; Chiantera, V; Maryam, S; Fought, AJ; McGree, ME; Mariani, A; Glaser, G
Prognostic value of isolated tumor cells in sentinel lymph nodes in intermediate-risk endometrial cancer: results from an international, multi-institutional study.
Int J Gynecol Cancer. 2025; 35(7):101906
Doi: 10.1016/j.ijgc.2025.101906
Web of Science
PubMed
FullText
FullText_MUG
** Lara, Gutierrez, A; Halbwedl, I; Sauer, S; Regitnig, P; Petru, E; Seeböck, R; Schubert, S; Peternell, C; Bodó, K; Prein, K; Kashofer, K
Robust assessment of HRD genomic instability by OncoScan microarrays.
J Mol Diagn. 2025;
Doi: 10.1016/j.jmoldx.2025.02.011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Neumann, CJ; Mohammadzadeh, R; Woh, PY; Kobal, T; Pausan, M-R; Shinde, T; Haid, V; Mertelj, P; Weiss, E-C; Kolovetsiou-Kreiner, V; Mahnert, A; Kumpitsch, C; Jantscher-Krenn, E; Moissl-Eichinger, C
First-year dynamics of the anaerobic microbiome and archaeome in infants' oral and gastrointestinal systems.
mSystems. 2025; 10(1):e0107124
Doi: 10.1128/msystems.01071-24
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rinnerthaler, G; Egle, D; Bartsch, R; Schmitt, CA; Petzer, A; Balic, M; Petru, E; Denison, U; Singer, CF; Bjelic-Radisic, V; Gampenrieder, SP; Knauer, M; Sotlar, K; Brunner, C; Posch, F; Hlauschek, D; Sölkner, L; Bago-Horvath, Z; Filipits, M; Gili, M; Ritter, M; Wieser, V; Albertini, C; Zaborsky, N; Weiss, L; Marhold, M; Schneeweiss, B; Pusch, R; Gnant, M; Greil, R
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.
Nat Cancer. 2025;
Doi: 10.1038/s43018-024-00890-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Singer, CF; Jahn, SW; Hlauschek, D; Heber, UM; Mang-Manger, C; Egle, D; Balic, M; Pichler, A; Pfeiler, G; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Petru, E; Greil, R; Bago-Horvath, Z; Deutschmann, C; Steger, GG; Seifert, M; Fitzal, F; Bartsch, R; Santhanagopal, A; Machacek-Link, J; Sellami, D; Schwarz, M; Fesl, C; Sölkner, L; Esker, S; Filipits, M; Gnant, M, , Austrian, Breast, and, Colorectal, Cancer, Study, Group
HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd.
Cancer Commun (Lond). 2025;
Doi: 10.1002/cac2.12657
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zaunschirm-Strutz, J; Rieder, A; Tocantins, C; Diniz, MS; Weiss, E; Hiden, U
MicroRNA profiling in umbilical cord plasma: links to maternal metabolism and neonatal metabolic and inflammatory traits.
J Physiol. 2025;
Doi: 10.1113/JP287672
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Petru, E; Schinnerl, M; Kolovetsiou, V
Endometrial cancer-news from ASCO 2024
MEMO-MAG EUR MED ONC. 2025;
Doi: 10.1007/s12254-024-01022-3
Web of Science
FullText
FullText_MUG
Abstract (Journal)
** Baerens, DT; Guth, D; Göhler, T; Janni, W; Pluschnig, U; Zahn, MO; Wuerstlein, R; Vannier, C; Maass, N; Petru, E
Treatment of HER2+/HR+ early breast cancer with neratinib: selected patient cases from a retrospective single case report retrieval project
BREAST. 2025; 80: 103910
Doi: 10.1016/j.breast.2025.103910
Web of Science
FullText
FullText_MUG
** Palmieri, E; Cucinella, G; Vitis, LAD; Zanagnolo, V; Multinu, F; Schivardi, G; Zhou, XC; Moriarty, K; Wallace, S; Alhilli, M; Joehlin-Price, A; Bogani, G; Raspagliesi, F; Tokgozoglu, N; Taskiran, C; Jagasia, N; Peiretti, M; Altieri, A; Ricotta, G; Mcalpine, J; Grassi, T; Bianchi, T; Landoni, F; Baiocchi, G; De Brot, L; Zapardiel, I; Hernandez-Gutierrez, A; Covens, A; Mitric, C; Tamussino, K; Wohlmuth, C; Chacon, E; Chiva, L; Vizzielli, G; Occhiali, T; Torne, A; Glickman, A; Kadan, Y; Laas-Faron, E; Di Guilmi, J; Nitschmann, C; Buda, A; Giuntoli, R; Mastroyannis, S; Pereira, A; Kurnit, K; Mcgree, M; Tapia, A; Scambia, G; Fanfani, F; Mariani, A; Glaser, G
Prognostic Significance Of Isolated Tumor Cells In Sentinel Lymph Nodes In Low-And Intermediate-Risk Endometrial Cancer Patients: Updated Results From An International Multi-Institutional Study
INT J GYNECOL CANCER. 2025; 35(2):
Doi: 10.1016/j.ijgc.2024.100084
Web of Science
FullText
FullText_MUG
** Singer, CF; Hlauschek, D; Egle, D; Bago-Horvath, Z; Pfeiler, G; Brunner, C; Peters-Engl, C; Petru, E; Reimer, DU; Pusch, R; Seifert, M; Pichler, P; Suppan, C; Reiner, A; Greil, R; Tan, YY; Bartsch, R; Knoll, K; Kermanidis, AS; Gnant, M
Prospective randomized phase II trial to assess the efficacy and safety of neo-adjuvant olaparib/carboplatin (OC) in comparison to docetaxel/epirubicin/cyclophosphamide (TAC) in patients with early triple-negative breast cancer (TNBC) with homologous recombination deficiency (HRD): Primary results from the ABCSG 45 trial.
J CLIN ONCOL. 2025; 43(16_SUPPL): 510
Doi: 10.1200/JCO.2025.43.16_suppl.510
Web of Science
FullText
FullText_MUG